IMAI Hisao

イマイヒサオ | IMAI Hisao

Affiliation and department：
Job title： Associate Professor
Papers (37)：

Koki Ito, Kyoichi Kaira, Hisao Imai, Ayako Shiono, Kosuke Hashimoto, OU Yamaguchi, Hiroshi Kagamu. Therapeutic Resistance in G-CSF Producing Lung Cancer With <I>EGFR</I> Mutation. CANCER DIAGNOSIS & PROGNOSIS. 2024. 4. 4. 529-533
Kyoichi Kaira, Atsuto Mouri, Hisao Imai, Ou Yamaguchi, Hiroshi Kagamu. Clinical Issue of Myasthenia Gravis Related to Immune Checkpoint Inhibitors. Current Oncology Reports. 2024
Kaira K, Ikezawa T, Inoue T, Imai H, Okada H, Kagamu H. MPO-ANCA positive glomerulonephritis during PD-1 inhibitor combined with anti-CTLA4 antibody in lung cancer. Journal of Chemother. 2024. 36. 1. 82-83
Yamaguchi O, Kaira K, Imai H, Mouri A, Shiono A, Miura Y, Hashimoto K, Kobayashi K, Kagamu H. Clinical Utility of Inflammatory and Nutritious Index as Therapeutic Prediction of Nivolumab plus Ipilimumab in Advanced Non-Small Cell Lung Cancer. Oncology. 2024. 102. 3. 271-282
Kasai T, Mori K, Nakamura Y, Seki N, Ichikawa Y, Saito H, Kondo T, Nishikawa K, Otsu S, Bessho A, et al. Randomized, Phase II study of pemetrexed plus bevacizumab versus pemetrexed alone after treatment with cisplatin, pemetrexed, and bevacizumab in advanced non-squamous, non-small cell lung cancer: TORG (thoracic oncology research group) 1321. Cancer Medicine. 2023. 12. 14. 14988-4999

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page